Picture courtesy The Indian Express
New Delhi: The Drugs Controller General of India (DCGI) has granted emergency use authorization to the COVID-19 vaccine Covovax for 12-17 years age group, PTI reported on Wednesday quoting official sources.
Covovax, the Indian version of US-developed Novavax, is manufactured in this country by Serun Institute of India.
It is the fourth COVID vaccine to receive regulator’s nod for use among under-18 age group.
The other three are Bharat Biotech’s Covaxin, which is being used to vaccinate those aged between 15 and 18 years after getting clearance last December; Zydus Cadila’s ZyCov-D which became the first one to be cleared by DCGI for those above 12 in August 2021; Biological E’s Corbevax for 12-18 years approved last month.
DCGI gave the nod to Covovax for emergency use authorization among adults on December 28, 2021, but it’s yet to be included in India’s vaccination drive.
Bhubaneswar: The National Highways Authority of India (NHAI) has initiated the process for the construction…
Ranchi/Bhubaneswar: Kalpana Soren, wife of Jharkhand Mukti Morcha (JMM) leader Hemant Soren Hemant Soren, was…
Mumbai: Once dubbed as the Chanakya of Maharashtra politics, Sharad Pawar has faced a significant…
Bhubaneswar: All the government departments in Odisha have been directed to ensure payment of full…
Bhubaneswar: The Odisha government has begun preparations for the five-day visit of President Droupadi Murmu…
Bhubaneswar: The state government is all set to amend the Odisha Universities (Amendment) Act, 2020…
Bhubaneswar: A low-pressure area formed over east Equatorial Indian Ocean and adjoining southeast Bay of…
Uttar Pradesh: The counting of votes for nine seats in the Uttar Pradesh Assembly bypolls…